AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2013
Feb 12, 2013
34931_dirs_2013-02-12_097b95d1-6294-4388-ad48-e6e629f2c255.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2013-02-11
Reporting Person: Potter Stephen W (Director)